Therefore, although we are able to conclude that high CAIX expression is an adverse prognostic factor and that particular antibodies have consistent prognostic value using standard scoring methods in patients with breast cancer, it is not clear what is the optimal prognostic cellular localisation. The gene discussed is CA9; the disease is breast carcinoma.